Filter
News & Insights
- Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
Sanofi acquires Dynavax for $2.2bn, adding Hepatitis B vax and shingles candidate
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
Zejing’s DLL3 cancer drug goes global with AbbVie co-sign
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
Merck reportedly in talks to buy Revolution in huge $28–32bn deal
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
Rumor has it: Sanofi eyes higher bid for retinal drug developer
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
Double take: Novartis signs back-to-back licensing agreements
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
Eikon Therapeutics sets sights on public markets
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
Parabilis Medicines’ latest financing round causes IPO whispers
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
Medline targets $5.37bn in landmark IPO
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
Aktis Oncology sets sights on first IPO of 2026
Read More - Startups & InnovatorsPartnering, Business Development & Licensing
Lisbon: Charting the New Course for European Life Sciences
Read More - Startups & InnovatorsPartnering, Business Development & Licensing
The integration advantage: How Novartis unified its deal-making operations
Read More - Startups & InnovatorsPartnering, Business Development & Licensing
The silver lining in Europe's biopharma storm
Read More - Startups & InnovatorsPartnering, Business Development & Licensing
Women's health investment surges, but systemic barriers remain
Read More - Startups & InnovatorsPartnering, Business Development & Licensing
Saudi Arabia's biotech ambitions take shape with $50m fund
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
During J. P. Morgan Healthcare Week, Biotech Showcase™ Provides Private and Micro- to Mid-Cap Public Company Executives One-Stop Access to Investors, Pharma Partners and Media
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
Biotech Showcase™ 2026 Returns to San Francisco During JPM Week as a Premier Destination for Dealmakers
Read More - Startups & InnovatorsPartnering, Business Development & Licensing
From roasts to billions: Navigating the biopharma investment landscape in 2025 Market Access
Read More - Startups & InnovatorsPartnering, Business Development & Licensing
BIO-Europe Panel Spotlights Urgent Need and Rising Optimism in Rare Disease Innovation
Read More - Startups & InnovatorsPartnering, Business Development & Licensing
The Future of Women's Health: Moving Beyond a Niche Market
Read More - Startups & InnovatorsPartnering, Business Development & Licensing
The Longevity Revolution: From Billionaire Obsession to Democratized Wellness
Read More